{"id":528866,"date":"2026-06-10T23:17:10","date_gmt":"2026-06-10T23:17:10","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/528866\/"},"modified":"2026-06-10T23:17:10","modified_gmt":"2026-06-10T23:17:10","slug":"ozempic-may-be-a-secret-weapon-against-adhd","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/528866\/","title":{"rendered":"Ozempic may be a secret weapon against ADHD"},"content":{"rendered":"

From shedding pounds and treating sleep apnea<\/a> to lowering the risk of heart attacks<\/a>, GLP-1s have rapidly evolved beyond their original purpose of treating Type 2 diabetes.<\/p>\n

Drugs like Ozempic and Wegovy are now being studied for a growing list of possible benefits, with early research pointing to possible effects on substance use disorders<\/a>, neurodegenerative diseases like Alzheimer\u2019s<\/a> and even cancer outcomes<\/a>. <\/p>\n

Now, social media users are claiming the blockbuster medications may have another surprising perk: easing symptoms of ADHD<\/a>.<\/p>\n

On social media, a growing chorus of people are saying that GLP-1 drugs are improving their ADHD. BillionPhotos.com \u2013 stock.adobe.com<\/p>\n

\u201cI have noticed a huge improvement with my procrastination,\u201d wrote one GLP-1 user with ADHD on a Reddit thread<\/a> about the strange side effect. \u201cI didn\u2019t even realize it until I noticed that things were getting done. Like \u2026 who did that? I did!\u201d<\/p>\n

\u201cI started [Ozempic] about a week ago and I have noticed an increase in energy and focus,\u201d commented another. \u201cI feel as though a fog has lifted in my brain and [I\u2019m] more motivated to do life than I have ever been.\u201d<\/p>\n

\u201cI\u2019m on Week 2 and it\u2019s insane how clear I am,\u201d chimed in a third. \u201cI got into a discussion with my husband and normally I\u2019d have fogged over or missed half my thoughts. I was clear and as sharp as a razor blade.\u201d<\/p>\n

ADHD \u2014 or attention-deficit\/hyperactivity disorder \u2014 affects roughly 15.5 million American adults<\/a> and an estimated 7 million children<\/a>. It\u2019s marked by persistent inattention, hyperactivity and impulsive behaviors that can disrupt daily life, relationships and work.<\/p>\n

Treatment typically involves behavioral therapy, medication or a combination of both to improve focus, emotional regulation and impulse control \u2014 but some patients taking GLP-1s say they\u2019re experiencing improvements they never achieved with traditional ADHD drugs.<\/p>\n

\u201cI have pretty severe ADHD, on meds for about 35 years. Some of them work decently, others don\u2019t,\u201d a Reddit user wrote. \u201cOne day after I started taking Ozempic, I started feeling like a superhero at work. My productivity is through the roof. No other medication has ever done this much for my ADHD.\u201d<\/p>\n

\n

\u201cI have seen a number of patients that have reported feeling better in terms of their ADHD symptoms when they went on GLP-1s.\u201d<\/p>\n

Dr. Lenard Adler<\/p><\/blockquote>\n

\u201cI\u2019ve taken Adderall for years but do not feel like it\u2019s as effective as it was before I was taking [GLP-1s],\u2019 another noted. \u201cI have been procrastinating way less and not being as impulsive shopping<\/a>-wise as I normally am.\u201d<\/p>\n

In clinical practice, Dr. Lenard Adler<\/a>, director of the Adult ADHD Program<\/a> at NYU Langone Health, said he\u2019s been hearing similar accounts from his own patients.<\/p>\n

Across the US, 1 in 8 American adults are using GLP-1s like Ozempic. mbruxelle \u2013 stock.adobe.com<\/p>\n

\u201cThere is no large database here,\u201d Adler, a psychiatrist, told The Post. \u201cBut I follow a couple hundred adults with ADHD, and anecdotally, I have seen a number of patients that have reported feeling better in terms of their ADHD symptoms when they went on GLP-1s.\u201d<\/p>\n

The most popular drugs in the GLP-1 receptor agonist<\/a> category use either semaglutide, the active ingredient in Ozempic and Wegovy, or tirzepatide, which powers Mounjaro and Zepbound.<\/p>\n

Adler said as many as 10% of the ADHD patients he treats are currently taking GLP-1s. Of those, he estimates roughly half have reported some improvement in their symptoms.<\/p>\n

\u201cIt\u2019s a small number, but it\u2019s notable,\u201d he said. <\/p>\n

Scientists still don\u2019t know whether the drugs directly improve ADHD symptoms. Currently, there are no active clinical trials specifically testing GLP-1 medications as a treatment for the disorder, according to ClinicalTrials.gov<\/a>. <\/p>\n

Still, Adler believes there are several plausible explanations for what patients are reporting. <\/p>\n

\u201cThe preclinical work done with the GLP-1s shows that they seem to affect the areas in the brain that are involved in reward<\/a>,\u201d he explained. \u201cSo the thinking is that it may involve impulse control and motivation.\u201d<\/p>\n

\n

\u201cI just started taking tirzepatide and I have literally never felt so relaxed in my life.\u201d<\/p>\n

A GLP-1 user with ADHD<\/p><\/blockquote>\n

Because of differences in dopamine pathways, motivation for the ADHD brain is often driven more by what feels stimulating or rewarding than by what simply needs to get done. As a result, even important tasks can feel impossible to begin or complete. <\/p>\n

\u201cMy biggest problem with ADHD is I am the biggest procrastinator,\u201d a Reddit user wrote. \u201cBut with Ozempic, I get everything started and actually finish it.\u201d<\/p>\n

GLP-1s target the brain\u2019s reward centers, which may explain the drug\u2019s effects on people with ADHD. Pakawadee \u2013 stock.adobe.com<\/p>\n

The same reward pathways are also linked to impulsivity, another hallmark ADHD trait. People with the disorder often struggle to resist behaviors that deliver a quick dopamine hit, but some patients say GLP-1s appear to be helping curb those urges.<\/p>\n

\u201cI\u2019m considering going off my Adderall,\u201d one Reddit user wrote. \u201cI\u2019ve been able to stop binge eating \u2026 I haven\u2019t been impulse shopping \u2026 I also don\u2019t pick at my skin. It\u2019s amazing to me.\u201d<\/p>\n

But Adler said that the reported benefits may not stem from the drugs alone. GLP-1 users typically lose between 15% and 25%<\/a> of their body weight over the course of a year, and he said the improvements some patients notice could be tied, at least in part, to the weight loss itself.<\/p>\n

\u201cOne thing that we don\u2019t know, and it\u2019s an area that we\u2019d like to investigate, is whether it\u2019s the weight loss that\u2019s leading to increased availability or their ADHD medicines,\u201d Adler said. <\/p>\n

\u201cWe also know that lifestyle issues affect ADHD symptoms, and if you lose weight and are able to become more active, you may be able to cope better with your symptoms.\u201d<\/p>\n

Whatever the reason, many patients say the drugs have quieted their mental chaos, bringing sharper focus, better self-control and a sense of calm that had previously felt out of reach.<\/p>\n

\u201cI\u2019ve been on the highest dose of semaglutide for a bit over 2 months and I finally feel what I cannot put into words,\u201d one wrote on Reddit. \u201cRelief. Contentment. Peace.\u201d<\/p>\n

\u201cI just started taking tirzepatide and I have literally never felt so relaxed in my life,\u201d remarked another. <\/p>\n

For Adler, stories like these underscore why the phenomenon deserves further study.<\/p>\n

\u201cI think it\u2019s an area that really does merit further research,\u201d he said. \u201cWe have patients that are on these medicines, and we need to better understand the potential effects of GLP-1s on ADHD symptoms directly \u2014 and potential side effects.\u201d<\/p>\n

Until scientists have more answers, Adler urged patients not to take matters into their own hands.<\/p>\n

\u201cIf patients are thinking about going on GLP-1s and they have ADHD, they need to talk to both their medical doctors and the clinician prescribing their ADHD meds, so that everybody\u2019s aware and coordinating their care,\u201d he stressed. <\/p>\n","protected":false},"excerpt":{"rendered":"From shedding pounds and treating sleep apnea to lowering the risk of heart attacks, GLP-1s have rapidly evolved…\n","protected":false},"author":2,"featured_media":528867,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[274],"tags":[16255,18,4500,20843,1950,135,19,17,462,167,2927,1114,564],"class_list":["post-528866","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-adhd","tag-eire","tag-exclusive","tag-experimental-drugs","tag-glp-1","tag-health","tag-ie","tag-ireland","tag-medication","tag-mental-health","tag-ozempic","tag-social-media","tag-weight-loss"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/116728368052571315","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/528866","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=528866"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/528866\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/528867"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=528866"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=528866"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=528866"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}